New pain block may keep diaphragm working after shoulder surgery
NCT ID NCT07587203
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two numbing medicines given as a nerve block before shoulder surgery. The goal is to see which one controls pain better while reducing the risk of temporary diaphragm paralysis (which can affect breathing). About 184 adults having shoulder surgery will take part. Results will help doctors choose the safest pain relief option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 184 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients scheduled for elective unilateral proximal humerus surgery, rotator cuff surgery, shoulder arthroplasty, or shoulder arthroscopy; * Visible diaphragmatic movement on the surgical side under ultrasound before anesthesia; * Patient provides informed consent; * Age 18-80 years, any gender; * ASA physical status I-III; * 18 kg/m² ≤ BMI ≤ 30 kg/m². Exclusion Criteria: * Coagulopathy; * Allergy to local anesthetics; * Infection at the puncture site; * History of chronic pain or opioid use; * Severe respiratory disease; * Pregnancy; * Diabetes and peripheral neuropathy; * Inability to understand assessment scales.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Proximal humerus surgery are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
-
Nanjing Gaochun People's Hospital
Nanjing, Jiangsu, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple wash stop the bacteria behind shoulder surgery infections?
- Standing x-rays may reveal what lying scans miss in shoulder replacement planning
- New shoulder implant put to the test against standard replacement
- Could a weaker nerve block mean less pain after shoulder surgery?
- Can a pinch of magnesium make nerve blocks last longer?
- Can big data improve shoulder replacement success?